189 related articles for article (PubMed ID: 15001264)
1. Early neuro-otologic effects of three-dimensional irradiation in children with primary brain tumors.
Merchant TE; Gould CJ; Xiong X; Robbins N; Zhu J; Pritchard DL; Khan R; Heideman RL; Krasin MJ; Kun LE
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1194-207. PubMed ID: 15001264
[TBL] [Abstract][Full Text] [Related]
2. Hearing loss after radiotherapy for pediatric brain tumors: effect of cochlear dose.
Hua C; Bass JK; Khan R; Kun LE; Merchant TE
Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):892-9. PubMed ID: 18395355
[TBL] [Abstract][Full Text] [Related]
3. Hearing Loss in Patients Who Received Cranial Radiation Therapy for Childhood Cancer.
Bass JK; Hua CH; Huang J; Onar-Thomas A; Ness KK; Jones S; White S; Bhagat SP; Chang KW; Merchant TE
J Clin Oncol; 2016 Apr; 34(11):1248-55. PubMed ID: 26811531
[TBL] [Abstract][Full Text] [Related]
4. Radiation dosimetry predicts IQ after conformal radiation therapy in pediatric patients with localized ependymoma.
Merchant TE; Kiehna EN; Li C; Xiong X; Mulhern RK
Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1546-54. PubMed ID: 16115736
[TBL] [Abstract][Full Text] [Related]
5. Ototoxic effect of cisplatin in children with brain tumors.
Cohen BH; Zweidler P; Goldwein JW; Molloy J; Packer RJ
Pediatr Neurosurg; 1990-1991; 16(6):292-6. PubMed ID: 2134738
[TBL] [Abstract][Full Text] [Related]
6. Sensorineural hearing loss in combined modality treatment of nasopharyngeal carcinoma.
Chen WC; Jackson A; Budnick AS; Pfister DG; Kraus DH; Hunt MA; Stambuk H; Levegrun S; Wolden SL
Cancer; 2006 Feb; 106(4):820-9. PubMed ID: 16421885
[TBL] [Abstract][Full Text] [Related]
7. Relative contributions of radiation and cisplatin-based chemotherapy to sensorineural hearing loss in head-and-neck cancer patients.
Hitchcock YJ; Tward JD; Szabo A; Bentz BG; Shrieve DC
Int J Radiat Oncol Biol Phys; 2009 Mar; 73(3):779-88. PubMed ID: 18707819
[TBL] [Abstract][Full Text] [Related]
8. Hearing Loss Risk in Pediatric Patients Treated with Cranial Irradiation and Cisplatin-Based Chemotherapy.
Cohen-Cutler S; Wong K; Mena V; Sianto K; Wright MA; Olch A; Orgel E
Int J Radiat Oncol Biol Phys; 2021 Aug; 110(5):1488-1495. PubMed ID: 33677052
[TBL] [Abstract][Full Text] [Related]
9. Changes in attentional performance of children and young adults with localized primary brain tumors after conformal radiation therapy.
Kiehna EN; Mulhern RK; Li C; Xiong X; Merchant TE
J Clin Oncol; 2006 Nov; 24(33):5283-90. PubMed ID: 17114662
[TBL] [Abstract][Full Text] [Related]
10. Radiation dose-volume effects on growth hormone secretion.
Merchant TE; Goloubeva O; Pritchard DL; Gaber MW; Xiong X; Danish RK; Lustig RH
Int J Radiat Oncol Biol Phys; 2002 Apr; 52(5):1264-70. PubMed ID: 11955738
[TBL] [Abstract][Full Text] [Related]
11. Hearing preservation in patients with vestibular schwannoma treated with Gamma Knife surgery.
Baschnagel AM; Chen PY; Bojrab D; Pieper D; Kartush J; Didyuk O; Naumann IC; Maitz A; Grills IS
J Neurosurg; 2013 Mar; 118(3):571-8. PubMed ID: 23216466
[TBL] [Abstract][Full Text] [Related]
12. Sensorineural hearing loss after treatment of nasopharyngeal carcinoma: a longitudinal analysis.
Chan SH; Ng WT; Kam KL; Lee MC; Choi CW; Yau TK; Lee AW; Chow SK
Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1335-42. PubMed ID: 18922648
[TBL] [Abstract][Full Text] [Related]
13. Dosimetric advantage of intensity-modulated radiotherapy for whole ventricles in the treatment of localized intracranial germinoma.
Sakanaka K; Mizowaki T; Hiraoka M
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):e273-80. PubMed ID: 21640515
[TBL] [Abstract][Full Text] [Related]
14. Late effects of conformal radiation therapy for pediatric patients with low-grade glioma: prospective evaluation of cognitive, endocrine, and hearing deficits.
Merchant TE; Conklin HM; Wu S; Lustig RH; Xiong X
J Clin Oncol; 2009 Aug; 27(22):3691-7. PubMed ID: 19581535
[TBL] [Abstract][Full Text] [Related]
15. Low-dose craniospinal irradiation and ifosfamide, cisplatin and etoposide for non-metastatic embryonal tumors in the central nervous system.
Yasuda K; Taguchi H; Sawamura Y; Ikeda J; Aoyama H; Fujieda K; Ishii N; Kashiwamura M; Iwasaki Y; Shirato H
Jpn J Clin Oncol; 2008 Jul; 38(7):486-92. PubMed ID: 18573848
[TBL] [Abstract][Full Text] [Related]
16. Predictors of hearing loss after gamma knife radiosurgery for vestibular schwannomas: age, cochlear dose, and tumor coverage.
Brown M; Ruckenstein M; Bigelow D; Judy K; Wilson V; Alonso-Basanta M; Lee JY
Neurosurgery; 2011 Sep; 69(3):605-13; discussion 613-4. PubMed ID: 21471832
[TBL] [Abstract][Full Text] [Related]
17. Ototoxicity in children with malignant brain tumors treated with the "8 in 1" chemotherapy protocol.
Ilveskoski I; Saarinen UM; Wiklund T; Perkkiö M; Salmi TT; Lanning M; Mäkipernaa A; Pihko H
Med Pediatr Oncol; 1996 Jul; 27(1):26-31. PubMed ID: 8614387
[TBL] [Abstract][Full Text] [Related]
18. Platinum compound-related ototoxicity in children: long-term follow-up reveals continuous worsening of hearing loss.
Bertolini P; Lassalle M; Mercier G; Raquin MA; Izzi G; Corradini N; Hartmann O
J Pediatr Hematol Oncol; 2004 Oct; 26(10):649-55. PubMed ID: 15454836
[TBL] [Abstract][Full Text] [Related]
19. Comparison of radiation and chemoradiation-induced sensorineural hearing loss in head and neck cancer patients.
Mahdavi SR; Rezaeyan A; Nikoofar A; Bakhshandeh M; Farahani S; Cheraghi S
J Cancer Res Ther; 2020; 16(3):539-545. PubMed ID: 32719264
[TBL] [Abstract][Full Text] [Related]
20. Prospective study of inner ear radiation dose and hearing loss in head-and-neck cancer patients.
Pan CC; Eisbruch A; Lee JS; Snorrason RM; Ten Haken RK; Kileny PR
Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1393-402. PubMed ID: 15817342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
